Apparent role of the macrophage growth factor, CSF-1, in placental development

Colony stimulating factor-1 (CSF-1) is a glycoprotein growth factor required for the proliferation and differentiation of mononuclear phagocytic cells (reviewed in ref. 1). A 10,000-fold elevation of mouse uterine CSF-1 during pregnancy, suggested by studies of the bone marrow colony stimulating activity of uterine extracts, was recently demonstrated by radioimmunoassay (RIA). This increase and the observations that placenta and choriocarcinoma cell lines express c-fms messenger RNA and the c-fms proto oncogene product (CSF-1 receptor) respectively, suggest an additional role for CSF-1 in pregnancy. We now show that uterine CSF-1 concentration is regulated by the synergistic action of female sex steroids, oestradiol-17 beta (E2) and progesterone (P) and that the elevation in CSF-1 concentration can be attributed to the preferential expression of an alternatively spliced CSF-1 mRNA by uterine glandular epithelial cells. These findings indicate that CSF-1, under hormonal influence, plays a role in placental development and function and that steroid hormones may regulate developmental processes via their effects on the expression of tissue-specific growth factors.     

南方鲶SME—1细胞系,草鱼CIK细胞系与原鱼种的RAPD图谱比较

研究了ＳＭＥ１和ＣＩＫ细胞系，以及南方鲶、鲶、大鳍、草鱼等６个样品的ＲＡＰＤ图谱，测定了各样品间的Ｎｅｉ相似系数和单匹配相似系数，并绘制了聚类树形图．Ｎｅｉ相似系数更适于细胞系与原种动物的相似性分析；细胞系与原鱼种的相似系数大于种间相似系数；培养时间短的ＳＭＥ１细胞与其原鱼种南方鲶的相似系数大于培养时间长的ＣＩＫ细胞与其原生鱼种草鱼的相似系数．     

人翻译延伸因子eEF1A1促进肺癌细胞H1299对紫杉醇和阿霉素药物耐受的研究

在已知人翻译延伸因子eEF1A的多功能性和与细胞存活相关的基础上,本文进一步研究eEF1A的变体蛋白eEF1A1对癌细胞耐药性的影响.eEF1A1基因的蛋白质编码区经过克隆,并瞬时转染了人肺癌细胞H1299,在确定eEF1A1蛋白的胞内表达后,采用MTT法测定高表达eEF1A1的H1299细胞对抗癌药物紫杉醇和阿霉素的耐受.相对于对照细胞,eEF1A1的高表达可显著提高H1299细胞对阿霉素和紫杉醇的耐受性.通过耐药性测试揭示出eEF1A可能参与肿瘤发生的潜在功能.     

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

Transgenic mice bearing the cellular myc oncogene coupled to the immunoglobulin mu or kappa enhancer frequently develop a fatal lymphoma within a few months of birth. Since the tumours represent represent both immature and mature B lymphocytes, constitutive c-myc expression appears to be highly leukaemogenic at several stages of B-cell maturation. These myc mice should aid study of lymphoma development, B-cell ontogeny and immunoglobulin regulation.     

人M-CSF与SCF融合蛋白的构建及其在昆虫细胞中的表达

应用重组DNA技术构建M-CSF与SCF的融合基因并将其克隆于昆虫杆状病毒转移载体pVL1392中,通过与野生型苜蓿夜蛾核型多角体病毒(AcNPV)DNA共转染草地夜蛾细胞Sf9,融合基因插入AcNPV基因组.重组病毒感染单层Sf9细胞后,表达产物分泌到胞外培养液中,用MTT比色法和TF-1细胞株可检测到表达产物与IL-3的协同效应.上述研究为开发具有应用价值的新型细胞融合因子奠定了基础.     

巨噬细胞移动抑制因子在宫颈癌组织中的表达及临床意义

目的探讨巨噬细胞移动抑制因子（MIF）在宫颈癌组织中的表达,评价其在宫颈癌发生、发展中的作用。方法采用免疫组化SP法检测42例宫颈癌组织及20例正常宫颈组织中MIF的表达。结果MIF在宫颈癌中的阳性表达率明显高于正常宫颈组织（P〈0．05）;MIF表达与宫颈癌的分化程度、临床分期及淋巴结转移密切相关（P〈0．05）,与病理类型及肿瘤直径无关联性（P〉0．05）。结论MIF可能在宫颈癌的发生及进展中起着重要的作用。     

干涉UBXN1慢病毒颗粒制备及稳定细胞系的建立

构建并鉴定UBXN1-shRNA慢病毒表达载体,以便应用RNAi技术以及慢病毒感染系统建立稳定干涉细胞系并进一步研究UBXN1的功能。将携带不同特异性干涉序列的DNA片段插入PLKO.1载体中构建慢病毒表达载体,并制备慢病毒颗粒。将慢病毒颗粒感染U2OS细胞,建立稳定干涉细胞系,应用real-time PCR和western blot技术分别检测U2OS细胞中UBXN1 mRNA和蛋白质水平的表达差异。重组克隆经酶切证实shRNA正确插入慢病毒载体,DNA测序证实插入的序列正确,western blot检测证实设计的五条shRNA干扰序列有效的敲低U2OS细胞中内源性UBXN1的表达。成功制备UBXN1的慢病毒干涉颗粒,并建立UBXN1稳定下调的U2OS细胞系。     

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

Mice homozygous for the recessive mutation osteopetrosis (op) on chromosome 3 have a restricted capacity for bone remodelling, and are severely deficient in mature macrophages and osteoclasts. Both cell populations originate from a common haemopoietic progenitor. As op/op mice are not cured by transplants of normal bone marrow cells, the defects in op/op mice may be associated with an abnormal haematopoietic microenvironment rather than with an intrinsic defect in haematopoietic progenitors. To investigate the molecular and biochemical basis of the defects caused by the op mutation, we established primary fibroblast cell lines from op/op mice and tested the ability of these cell lines to support the proliferation of macrophage progenitors. We show that op/op fibroblasts are defective in production of functional macrophage colony-stimulating factor (M-CSF), although its messenger RNA (Csfm mRNA) is present at normal levels. This defect in M-CSF production and the recent mapping of the Csfm structural gene near op on chromosome 3 suggest that op is a mutation within the Csfm gene itself. We have sequenced Csfm complementary DNA prepared from op/op fibroblasts and found a single base pair insertion in the coding region of the Csfm gene that generates a stop codon 21 base pairs downstream. Thus, the op mutation is within the Csfm coding region and we conclude that the pathological changes in this mutant result from the absence of M-CSF.     

Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

Activation of naive CD4(+) T-helper cells results in the development of at least two distinct effector populations, Th1 and Th2 cells. Th1 cells produce cytokines (interferon (IFN)-gamma, interleukin (IL)-2, tumour-necrosis factor (TNF)-alpha and lymphotoxin) that are commonly associated with cell-mediated immune responses against intracellular pathogens, delayed-type hypersensitivity reactions, and induction of organ-specific autoimmune diseases. Th2 cells produce cytokines (IL-4, IL-10 and IL-13) that are crucial for control of extracellular helminthic infections and promote atopic and allergic diseases. Although much is known about the functions of these two subsets of T-helper cells, there are few known surface molecules that distinguish between them. We report here the identification and characterization of a transmembrane protein, Tim-3, which contains an immunoglobulin and a mucin-like domain and is expressed on differentiated Th1 cells. In vivo administration of antibody to Tim-3 enhances the clinical and pathological severity of experimental autoimmune encephalomyelitis (EAE), a Th1-dependent autoimmune disease, and increases the number and activation level of macrophages. Tim-3 may have an important role in the induction of autoimmune diseases by regulating macrophage activation and/or function.     

MTA1基因在肝癌细胞系HepG_2及其异质性亚系中表达的差异性

目的:探讨MTA1基因在肝癌细胞系HepG2及其异质性亚系中的表达水平.方法:采用半定量RT-PCR、荧光定量RT-PCR的方法检测3种细胞中MTA1基因的表达差异;Western blotting检测蛋白水平的表达差异;用细胞免疫组织化学方法观察MTA1蛋白的细胞定位.结果:HepG2-H和HepG2细胞株的mRNA和蛋白表达水平均高于HepG2-L细胞株;细胞免疫组化显示3株细胞的MTA1蛋白均定位于细胞核和细胞浆,以细胞核为主.结论:MTA1基因在具有不同转移潜能的肝癌细胞亚系HepG2-H、HepG2-L中的表达具有明显差异.     

c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells

Several lines of evidence suggest a role for the myc oncogene in cell proliferation. Most recently, mitogenic stimulation of quiescent lymphoid, fibroblast and epithelial cells has been demonstrated to lead to a sharp increase in c-myc RNA levels. To determine how c-myc expression is linked to the cell proliferative cycle, we have used centrifugal elutriation to enrich for populations of avian and human cells at different stages of the cell cycle. Centrifugal elutriation is a counterflow centrifugation method that separates cells on the basis of volume, a parameter correlating well with progression through the cell cycle. Using myc-specific anti-peptide antibodies, we show here that the synthesis, half-life and modification of c-myc proteins are constant throughout the cell cycle of normal and transformed cells.     

Rho激酶抑制剂诱导PC12和PC12Adh细胞突起生长的差异比较

 PC12细胞是研究神经分化最常用的细胞之一.在rho激酶(ROCK)抑制剂的作用下,PC12细胞能够长出神经样突起.最近,美国菌种保存中心(ATCC)同时提供PC12细胞和PC12 Adh细胞.研究的主要目的是观察ROCK抑制剂诱导这2种细胞长突起是否存在差异.PC12细胞和PC12Adh细胞按照ATCC方法进行培养,用神经生长因子(NGF,1000ng/mL)或ROCK抑制剂(33μmol/L Y27632,33μmol/L法舒地尔)处理细胞1~4d.结果发现NGF能够诱导这2种细胞生长突起,而ROCK抑制剂只诱导PC12Adh细胞长突起,对PC12细胞不明显.因此,ROCK抑制剂诱导这2种细胞突起生长存在明显差异,PC12Adh细胞更适合用于ROCK抑制剂的神经诱导分化实验.     

RNA干扰沉默PID1基因在C2C12细胞中表达的研究

 构建和筛选对PID1（phosphotyrosine interaction domain containing 1, PID1）基因有RNA干扰作用的PID1-shRNA表达载体。据小鼠PID1 cDNA序列,优化设计了4条shRNA及1条阴性干扰序列,插入pGPU6/GFP/Neo载体中,得到pGPU6/GFP/Neo-PID1-1、pGPU6/GFP/Neo-PID1-2、pGPU6/GFP/Neo-PID1-3、pGPU6/GFP/Neo PID1 4和pGPU6/GFP/Neo-PID1-NC。干扰载体转染C2C12细胞,以RT-PCR和Western blot技术检测shRNA对C2C12细胞中PID1 mRNA和蛋白表达的下调作用。结果表明：靶向PID1基因的4个shRNA重组质粒载体经测序分析,其shRNA编码序列与预期设计的完全一致,经酶切鉴定和测序分析证实,靶向PID1基因的shRNA重组质粒载体构建成功。进一步将构建的4个表达载体分别转染C2C12细胞,24h后细胞中PID1基因mRNA表达水平依次下调 (23.58±1.87)%、(75.44±0.77)%、(70.52±0.41)% 和 (56.60±3.13)%。48 h后细胞中PID1蛋白表达水平依次降低 (30.15±5.05)%、(71.86±4.85)%、(67.93±2.28)% 和 (56.81±2.01)%。所筛选出的pGPU6/GFP/Neo-PID1-2、pGPU6/GFP/Neo-PID1-3和pGPU6/GFP/Neo-PID1-4三个表达载体均能高效地抑制转染细胞PID1 mRNA和蛋白的表达,为进一步研究PID1基因的功能奠定了基础。